FREDERICK, MD and BARCELONA, SPAIN--(Marketwired - May 11, 2016) - Welocalize, global leader in innovative translation and localization solutions, has acquired Nova Traductors i Intèrprets, S.L., doing business as Nova Language Services (Nova). The company is headquartered in Barcelona, Spain, and is strategically important to Welocalize's growing portfolio of regulated industry language solutions for life sciences, including biotechnology, pharmaceutical, medical device companies, and contract research organizations.
Founded in 1998, Nova, provides specialized translation and localization services to multinational businesses. Based in Europe, the company also has operations in North America and Asia. Nova provides expert translation services for clinical research, patient recruitment, regulatory affairs, medical devices, as well as general translation services and interpretation.
"The Nova acquisition is a game-changer for us in the life sciences space as we can now offer globalization services across the complete product lifecycle from intellectual property through Park IP Translations, clinical trials with our Nova brand, global digital marketing through Adapt Worldwide and localization and quality validation services with Welocalize," said Smith Yewell, CEO and co-founder of Welocalize. "Our customers can count on us to protect, market, deliver and validate their global products all in one easy to manage partnership."
"Nova, now a Welocalize company, is an exciting add on to our regulatory services in an area we have been expanding for some time," said Erin Wynn, chief customer officer for regulated industries at Welocalize. "Nova is a perfect fit because of their market leadership, along with proven capabilities and know-how and together we are able to rapidly expand our industry-specific language services across geographies and languages in this ever growing life sciences industry." Erin Wynn is also the general manager of Welocalize's legal language solutions entity, Park IP Translations, based in New York City.
"We are most excited about joining forces with Welocalize for its global presence and providing expansion opportunities in other regions beyond Europe and adding depth to our current services," said Consol Casablanca, founder and general manager of Nova, a Welocalize company.
Nova, a Welocalize company, will remain headquartered in Barcelona and take full advantage of the 19 Welocalize global offices in the United Kingdom, United States, Ireland, Germany, Spain, Italy, Romania, Poland, China and Japan.
Welocalize, Inc., founded in 1997, offers innovative language services to help global brands reach audiences around the world in more than 175 languages. We provide translation and localization services, talent management, language tools, automation and technology, quality and program management. Our range of managed language services include machine translation, digital marketing, validation and testing, interpretation, staffing and enterprise translation management technologies. We specialize in consumer, technology, manufacturing, learning, oil and gas, travel and hospitality, marketing and advertising, finance, legal and life sciences industry language solutions. With more than 800 employees worldwide, Welocalize maintains offices in the United States, United Kingdom, Germany, Ireland, Spain, Italy, Romania, Poland, Japan and China. www.welocalize.com
Nova, a Welocalize company, provides regulated industry language solutions including translation, web and marketing localization, interpretation and multimedia services. Nova primarily focuses on services for the life sciences industry, including biotechnology, pharmaceutical and medical device, with emphasis on specialized language solutions for clinical research, patient recruitment, medical device content, compliance and regulatory affairs material. Nova was established in 1998 and is headquartered in Barcelona. As a Welocalize company, Nova has 19 global offices and provide language solutions in 175 languages. www.nova-transnet.com and www.translate-lifescience.com